Table 1 Total number of studies and participants per antimalarial drug, with number of studies including children and pregnant women
Drug | Total number of studies | Total number of participants who had drug | Total number of participants who had ECGs | Total number of studies which included children | Total number of studies which included pregnant women | Total number of studies which included pharmacokinetic analysis |
|---|---|---|---|---|---|---|
Quinine | 51 | 2611 | 2320 | 18 | 1 | 19 |
Mefloquine | 45 | 7874 | 3099 | 13 | 2 | 19 |
Lumefantrine | 39 | 5703 | 4787 | 19 | 3 | 19 |
Piperaquine | 24 | 15,224 | 5083 | 7 | 1 | 12 |
Halofantrine | 22 | 822 | 774 | 7 | 0 | 10 |
Chloroquine | 17 | 1207 | 1076 | 6 | 0 | 10 |
Sulfadoxine-pyrimethamine | 14 | 1288 | 695 | 4 | 2 | 5 |
Amodiaquine | 10 | 569 | 452 | 2 | 1 | 8 |
Primaquine | 7 | 150 | 150 | 0 | 0 | 4 |